The administration of drugs and vaccines by the intranasal route [editorial].

This publication has 26 references indexed in Scilit:

• RUBELLA-SPECIFIC SERUM AND NASOPHARYNGEAL IMMUNOGLOBULIN RESPONSES FOLLOWING NATURALLY ACQUIRED AND VACCINE-INDUCED INFECTION PROLONGED PERSISTENCE OF VIRUS-SPECIFIC IgM
  The Lancet, 1975
• The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines
  Epidemiology and Infection, 1973
• Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory Studies
  BMJ, 1973
• Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States
  JAMA, 1973
• Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H₃N₂) influenza vaccines A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines
  Epidemiology and Infection, 1972
• Trials of intranasally administered rubella vaccine
  Epidemiology and Infection, 1971
• Intranasal vaccination with RA 27/3 attenuated rubella virus
  The Journal of Pediatrics, 1971
• A COMPARISON OF LIVE AND KILLED INFLUENZA-VIRUS VACCINES: Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines
  The Lancet, 1968
• Experiments on the spread of colds: II. Studies in volunteers with coxsackievirus A21
  Epidemiology and Infection, 1965
• Studies on respiratory infection: I. The influence of particle size on respiratory infection with anthrax spores
  Epidemiology and Infection, 1953